TNFSF10 and melanoma: In TRAIL-resistant A375 melanoma cells, U37883A can potentiate TRAIL-induced cell death as rapidly as within 24 h, while glibenclamide is ineffective, despite considerable potentiation of TRAIL-induced ΔΨm collapse and caspase-3/7 activation.